IL140759A0 - Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies - Google Patents

Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Info

Publication number
IL140759A0
IL140759A0 IL14075999A IL14075999A IL140759A0 IL 140759 A0 IL140759 A0 IL 140759A0 IL 14075999 A IL14075999 A IL 14075999A IL 14075999 A IL14075999 A IL 14075999A IL 140759 A0 IL140759 A0 IL 140759A0
Authority
IL
Israel
Prior art keywords
vitamin
vulvitis
esters
topical treatment
dryness
Prior art date
Application number
IL14075999A
Other languages
English (en)
Original Assignee
Panin Giorgio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL140759(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Panin Giorgio filed Critical Panin Giorgio
Publication of IL140759A0 publication Critical patent/IL140759A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
IL14075999A 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies IL140759A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
PCT/IB1999/001238 WO2000002554A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Publications (1)

Publication Number Publication Date
IL140759A0 true IL140759A0 (en) 2002-02-10

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14075999A IL140759A0 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Country Status (22)

Country Link
EP (1) EP1094807B1 (pt)
JP (1) JP2002520281A (pt)
CN (1) CN1135975C (pt)
AT (1) ATE238051T1 (pt)
AU (1) AU762860B2 (pt)
BR (1) BR9911945A (pt)
CA (1) CA2336990A1 (pt)
CZ (1) CZ301019B6 (pt)
DE (1) DE69907193T2 (pt)
DK (1) DK1094807T3 (pt)
ES (1) ES2196813T3 (pt)
HU (1) HU228921B1 (pt)
IL (1) IL140759A0 (pt)
IT (1) ITMI981586A1 (pt)
NO (1) NO20006719L (pt)
NZ (1) NZ509129A (pt)
PL (1) PL345500A1 (pt)
PT (1) PT1094807E (pt)
RU (2) RU2221561C2 (pt)
SK (1) SK284464B6 (pt)
TR (2) TR200100014T2 (pt)
WO (1) WO2000002554A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
CN102238949A (zh) * 2008-10-09 2011-11-09 拉姆斯科股份有限公司 治疗干眼综合征的组合物和方法
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
ES2441227T3 (es) * 2009-07-27 2014-02-03 Salvatore Troisi Disolución oftálmica para la protección de las estructuras internas del globo ocular frente a los rayos UV-A o para el tratamiento del queratocono con una técnica de entrecruzamiento transepitelial
AU2012315545B2 (en) 2011-09-29 2017-03-09 Plx Opco Inc. pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
US10251861B2 (en) * 2012-06-08 2019-04-09 Ohio State Innovation Foundation Methods for treating burn and scar injury using tocotrienol compositions
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
AU2015335204B2 (en) * 2014-10-22 2020-10-08 Hulka S.R.L. Pharmaceutical composition for use in increasing the trophism of nasal mucosa
WO2016146843A1 (en) * 2015-03-18 2016-09-22 Bionoox Suisse Sa Compositions comprising dihydroquercetin for use in methods for treating herpes
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
US11576926B2 (en) * 2018-09-12 2023-02-14 Neilos S.r.l. Composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) * 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
CA3172595A1 (en) 2020-03-26 2021-09-30 Ronald Zimmerman Pharmaceutical carriers capable of ph dependent reconstitution and methods for making and using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
ES2196813T3 (es) 2003-12-16
SK352001A3 (en) 2001-06-11
HUP0102781A3 (en) 2002-04-29
NO20006719D0 (no) 2000-12-29
SK284464B6 (sk) 2005-04-01
WO2000002554A1 (en) 2000-01-20
ATE238051T1 (de) 2003-05-15
CN1135975C (zh) 2004-01-28
PT1094807E (pt) 2003-08-29
RU2221561C2 (ru) 2004-01-20
AU762860B2 (en) 2003-07-10
CZ301019B6 (cs) 2009-10-14
TR200103710T2 (tr) 2002-06-21
AU4385899A (en) 2000-02-01
PL345500A1 (en) 2001-12-17
CN1308531A (zh) 2001-08-15
DE69907193T2 (de) 2004-04-08
NZ509129A (en) 2003-10-31
CZ200136A3 (cs) 2001-08-15
EP1094807A1 (en) 2001-05-02
EP1094807B1 (en) 2003-04-23
HUP0102781A2 (hu) 2001-12-28
DK1094807T3 (da) 2003-08-11
BR9911945A (pt) 2001-03-27
TR200100014T2 (tr) 2001-06-21
DE69907193D1 (de) 2003-05-28
HU228921B1 (en) 2013-06-28
ITMI981586A1 (it) 2000-01-10
NO20006719L (no) 2001-02-16
ITMI981586A0 (it) 1998-07-10
JP2002520281A (ja) 2002-07-09
CA2336990A1 (en) 2000-01-20
RU2003128023A (ru) 2005-04-10

Similar Documents

Publication Publication Date Title
IL140759A0 (en) Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
NO20044699L (no) Vaginalpleiesammensetning
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
JP2004508296A5 (pt)
EP1690539A3 (de) Tiotropiumsalze zur Behandlung von inflammatorischen Erkrankungen
UA81638C2 (ru) Композиция метронидазола для местного применения для лечения заболеваний аноректального и перианального участков
PT1147110E (pt) Derivados de pirazino (aza)-indol
WO1999053897A3 (en) Topical formulation comprising poloxamers and further microbicides, and an applicator
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
WO2003070178A3 (en) Throat spray
NO20025510D0 (no) Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
ATE360428T1 (de) Analgetisches arzneimittel
HK1058515A1 (en) Use of pamoic acid for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates.
DK1105141T3 (da) Phosphatidylcholin som et medikament med slimhindebeskyttende virkning
CN101168044B (zh) 一种女士日常护理凝胶的产品配方
FR2802097B1 (fr) Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
WO1999058107A3 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
JPS6447717A (en) Infectious disease preventing drug
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
ITMI991144A1 (it) Acido tricloroacetico per la preparazione di soluzioni e/o composizioni per il trattamento di lesioni erosive e/o ulcerative
UA41100A (uk) Вагінальний супозиторій для лікування запальних захворювань піхви та вульви
RU2000106782A (ru) Применение препарата "юницивин" для лечения воспалительных процессов в матке женщин
RU2003117503A (ru) Способ лечения и профилактики рецидивов генитальной папилломавирусной инфекции